22 SEPTEMBER 2009

NORTHERN INVESTORS COMPANY PLC

PORTFOLIO UPDATE


Northern Investors Company PLC ("the Company") announces the sale of
its investment in DxS Limited, which provides molecular diagnostic
products and services to the healthcare industry, for initial cash
proceeds of £5.9 million, plus £0.3 million by way of accrued loan
stock interest and preference dividends.  The Company may become
entitled to receive up to a further £3.9 million over the period to
2012 subject to the achievement by DxS of specified objectives.

The initial sale price represents an uplift of £1.0 million
(equivalent to 5.3p per ordinary share in the Company) over the
carrying value of the investment as reflected in the unaudited net
asset value of 242.6p per share as at 30 June 2009 which was
announced by the Company on 30 July 2009.

The Company invested a total of £0.8 million in DxS in a series of
early-stage funding rounds led by NVM Private Equity between 2001 and
2006.  The total income and capital proceeds to date (excluding
contingent future payments) represent a money multiple of 7.5 times
the original investment and an internal rate of return (IRR) of 31.7%
per annum.


Enquiries:

Tim Levett/Christopher Mellor, NVM Private Equity Limited - 0191 244
6000

---END OF MESSAGE---




This announcement was originally distributed by Hugin. The issuer is 
solely responsible for the content of this announcement.